請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43010
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林中天 | |
dc.contributor.author | Nien-Yi Lin | en |
dc.contributor.author | 林念儀 | zh_TW |
dc.date.accessioned | 2021-06-15T01:32:41Z | - |
dc.date.available | 2009-09-01 | |
dc.date.copyright | 2009-07-23 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-20 | |
dc.identifier.citation | 1. Kiess, W., Petzold, S., Topfer, M., Garten, A., Bluher, S., Kapellen, T., Korner, A. and Kratzsch, J. (2008) Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol Metab, 22, 135-153.
2. Ntambi, J.M. and Young-Cheul, K. (2000) Adipocyte differentiation and gene expression. J Nutr, 130, 3122S-3126S. 3. Lau, D.C.W., Dhillon, B., Yan, H., Szmitko, P.E. and Verma, S. (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol, 288, H2031-2041. 4. Smith, S.R., Lovejoy, J.C., Greenway, F., Ryan, D., deJonge, L., de la Bretonne, J., Volafova, J. and Bray, G.A. (2001) Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism, 50, 425-435. 5. Cannon, B. and Nedergaard, J.A.N. (2004) Brown Adipose Tissue: Function and Physiological Significance. Physiol. Rev., 84, 277-359. 6. Oberkofler, H., Dallinger, G., Liu, Y.M., Hell, E., Krempler, F. and Patsch, W. (1997) Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans. J. Lipid Res., 38, 2125-2133. 7. Krief, S., Lonnqvist, F., Raimbault, S., Baude, B., Van Spronsen, A., Arner, P., Strosberg, A.D., Ricquier, D. and Emorine, L.J. (1993) Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest, 91, 344-349. 8. Cousin, B., Cinti, S., Morroni, M., Raimbault, S., Ricquier, D., Penicaud, L. and Casteilla, L. (1992) Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci, 103, 931-942. 9. Gesta, S., Tseng, Y.H. and Kahn, C.R. (2007) Developmental origin of fat: tracking obesity to its source. Cell, 131, 242-256. 10. Cinti, S. (2005) The adipose organ. Prostaglandins Leukot Essent Fatty Acids, 73, 9-15. 11. Bartness, T.J. and Bamshad, M. (1998) Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol Regul Integr Comp Physiol, 275, R1399-1411. 12. Cinti, S. (2002) Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinol Invest, 25, 823-835. 13. van Dijk, G. (2001) The role of leptin in the regulation of energy balance and adiposity. J Neuroendocrinol, 13, 913-921. 14. Kim, S. and Moustaid-Moussa, N. (2000) Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr, 130, 3110S-3115S. 15. Trayhurn, P. and Beattie, J.H. (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc, 60, 329-339. 16. Henry, B.A. and Clarke, I.J. (2008) Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol, 20, 842-849. 17. Cinti, S., Frederich, R.C., Zingaretti, M.C., De Matteis, R., Flier, J.S. and Lowell, B.B. (1997) Immunohistochemical Localization of Leptin and Uncoupling Protein in White and Brown Adipose Tissue. Endocrinology, 138, 797-804. 18. Himms-Hagen, J. (2001) Does brown adipose tissue (BAT) have a role in the physiology or treatment of human obesity? Rev Endocr Metab Disord, 2, 395-401. 19. Avram, A.S., Avram, M.M. and James, W.D. (2005) Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol, 53, 671-683. 20. Reeves, G.K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull, D. and Million Women Study, C. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134-. 21. Renehan, A.G., Tyson, M., Egger, M., Heller, R.F. and Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet, 371, 569-578. 22. Renehan, A.G., Frystyk, J. and Flyvbjerg, A. (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab, 17, 328-336. 23. Novakofski, J. (2004) Adipogenesis: usefulness of in vitro and in vivo experimental models. J Anim Sci, 82, 905-915. 24. Phillips, B.W., Vernochet, C. and Dani, C. (2003) Differentiation of embryonic stem cells for pharmacological studies on adipose cells. Pharmacol Res, 47, 263-268. 25. Morganstein, D.L., Christian, M., Turner, J.J.O., Parker, M.G. and White, R. (2008) Conditionally immortalized white preadipocytes: a novel adipocyte model. J. Lipid Res., 49, 679-685. 26. Novakofski, J. (2004) Adipogenesis: Usefulness of in vitro and in vivo experimental models. J. Anim Sci., 82, 905-915. 27. MacDougald, O.A. and Lane, M.D. (1995) Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem, 64, 345-373. 28. Tang, Q.Q., Otto, T.C. and Lane, M.D. (2003) Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A, 100, 44-49. 29. Wu, Z., Rosen, E.D., Brun, R., Hauser, S., Adelmant, G., Troy, A.E., McKeon, C., Darlington, G.J. and Spiegelman, B.M. (1999) Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell, 3, 151-158. 30. Kim, J.B., Wright, H.M., Wright, M. and Spiegelman, B.M. (1998) ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci U S A, 95, 4333-4337. 31. Feve, B. (2005) Adipogenesis: cellular and molecular aspects. Best Pract Res Clin Endocrinol Metab, 19, 483-499. 32. Johnson, G.L. and Lapadat, R. (2002) Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases. Science, 298, 1911-1912. 33. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-e., Karandikar, M., Berman, K. and Cobb, M.H. (2001) Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions. Endocr Rev, 22, 153-183. 34. Wada, T. and Penninger, J.M. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 2838-2849. 35. Owens, D.M. and Keyse, S.M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene, 26, 3203-3213. 36. Keyse, S.M. (2008) Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev, 27, 253-261. 37. Dhillon, A.S., Hagan, S., Rath, O. and Kolch, W. (2007) MAP kinase signalling pathways in cancer. Oncogene, 26, 3279-3290. 38. Yip-Schneider, M.T., Lin, A. and Marshall, M.S. (2001) Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun, 280, 992-997. 39. Binetruy, B., Heasley, L., Bost, F., Caron, L. and Aouadi, M. (2007) Concise Review: Regulation of Embryonic Stem Cell Lineage Commitment by Mitogen-Activated Protein Kinases. Stem Cells, 25, 1090-1095. 40. Rosen, E.D. and Spiegelman, B.M. (2000) Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol, 16, 145-171. 41. Burns, K.A. and Vanden Heuvel, J.P. (2007) Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta, 1771, 952-960. 42. Engelman, J.A., Lisanti, M.P. and Scherer, P.E. (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem, 273, 32111-32120. 43. Batchvarova, N., Wang, X.Z. and Ron, D. (1995) Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J, 14, 4654-4661. 44. Ho, I.C., Kim, J.H., Rooney, J.W., Spiegelman, B.M. and Glimcher, L.H. (1998) A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. Proc Natl Acad Sci U S A, 95, 15537-15541. 45. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., Karin, M. and Hotamisligil, G.S. (2002) A central role for JNK in obesity and insulin resistance. Nature, 420, 333-336. 46. Zick, Y. (2001) Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends in Cell Biology, 11, 437-441. 47. Slack, D.N., Seternes, O.M., Gabrielsen, M. and Keyse, S.M. (2001) Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem, 276, 16491-16500. 48. Wu, G. (2007) Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer and Metastasis Reviews, 26, 579-585. 49. Wang, J., Zhou, J.Y. and Wu, G.S. (2007) ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells. Cancer Res, 67, 11933-11941. 50. Chattopadhyay, S., Machado-Pinilla, R., Manguan-Garcia, C., Belda-Iniesta, C., Moratilla, C., Cejas, P., Fresno-Vara, J.A., de Castro-Carpeno, J., Casado, E., Nistal, M. et al. (2006) MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene, 25, 3335-3345. 51. Wang, H.Y., Cheng, Z. and Malbon, C.C. (2003) Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett, 191, 229-237. 52. Magi-Galluzzi, C., Mishra, R., Fiorentino, M., Montironi, R., Yao, H., Capodieci, P., Wishnow, K., Kaplan, I., Stork, P.J. and Loda, M. (1997) Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest, 76, 37-51. 53. Loda, M., Capodieci, P., Mishra, R., Yao, H., Corless, C., Grigioni, W., Wang, Y., Magi-Galluzzi, C. and Stork, P.J. (1996) Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol, 149, 1553-1564. 54. Lang, R., Hammer, M. and Mages, J. (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol, 177, 7497-7504. 55. Wang, X. and Liu, Y. (2007) Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal, 19, 1372-1382. 56. Chi, H., Barry, S.P., Roth, R.J., Wu, J.J., Jones, E.A., Bennett, A.M. and Flavell, R.A. (2006) Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A, 103, 2274-2279. 57. Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A.C. and Lang, R. (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med, 203, 15-20. 58. Salojin, K.V., Owusu, I.B., Millerchip, K.A., Potter, M., Platt, K.A. and Oravecz, T. (2006) Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol, 176, 1899-1907. 59. Zhao, Q., Wang, X., Nelin, L.D., Yao, Y., Matta, R., Manson, M.E., Baliga, R.S., Meng, X., Smith, C.V., Bauer, J.A. et al. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med, 203, 131-140. 60. Lasa, M., Abraham, S.M., Boucheron, C., Saklatvala, J. and Clark, A.R. (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol, 22, 7802-7811. 61. Chen, P., Li, J., Barnes, J., Kokkonen, G.C., Lee, J.C. and Liu, Y. (2002) Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol, 169, 6408-6416. 62. Sakaue, H., Ogawa, W., Nakamura, T., Mori, T., Nakamura, K. and Kasuga, M. (2004) Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation. J Biol Chem, 279, 39951-39957. 63. Wu, J.J., Roth, R.J., Anderson, E.J., Hong, E.G., Lee, M.K., Choi, C.S., Neufer, P.D., Shulman, G.I., Kim, J.K. and Bennett, A.M. (2006) Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab, 4, 61-73. 64. Sun, H., Charles, C.H., Lau, L.F. and Tonks, N.K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell, 75, 487-493. 65. Sgambato, V., Pages, C., Rogard, M., Besson, M.J. and Caboche, J. (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J Neurosci, 18, 8814-8825. 66. Wong, H.R., Dunsmore, K.E., Page, K. and Shanley, T.P. (2005) Heat shock-mediated regulation of MKP-1. Am J Physiol Cell Physiol, 289, C1152-1158. 67. Bost, F., Aouadi, M., Caron, L. and Binetruy, B. (2005) The role of MAPKs in adipocyte differentiation and obesity. Biochimie, 87, 51-56. 68. Kren, B.T. and Steer, C.J. (1996) Posttranscriptional regulation of gene expression in liver regeneration: role of mRNA stability. FASEB J., 10, 559-573. 69. Houseley, J. and Tollervey, D. (2009) The many pathways of RNA degradation. Cell, 136, 763-776. 70. Beelman, C.A. and Parker, R. (1995) Degradation of mRNA in eukaryotes. Cell, 81, 179-183. 71. Guhaniyogi, J. and Brewer, G. (2001) Regulation of mRNA stability in mammalian cells. Gene, 265, 11-23. 72. Ross, J. (1995) mRNA stability in mammalian cells. Microbiol. Rev., 59, 423-450. 73. Bakheet, T., Frevel, M., Williams, B.R.G., Greer, W. and Khabar, K.S.A. (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucl. Acids Res., 29, 246-254. 74. Chen, C.-Y.A. and Shyu, A.-B. (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences, 20, 465-470. 75. Barreau, C., Paillard, L. and Osborne, H.B. (2006) AU-rich elements and associated factors: are there unifying principles? Nucl. Acids Res., 33, 7138-7150. 76. Bakheet, T., Frevel, M., Williams, B.R., Greer, W. and Khabar, K.S. (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res, 29, 246-254. 77. Couttet, P., Fromont-Racine, M., Steel, D., Pictet, R. and Grange, T. (1997) Messenger RNA deadenylylation precedes decapping in mammalian cells. Proc Natl Acad Sci U S A, 94, 5628-5633. 78. Mukherjee, D., Gao, M., O'Connor, J.P., Raijmakers, R., Pruijn, G., Lutz, C.S. and Wilusz, J. (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J, 21, 165-174. 79. Kedersha, N., Stoecklin, G., Ayodele, M., Yacono, P., Lykke-Andersen, J., Fritzler, M.J., Scheuner, D., Kaufman, R.J., Golan, D.E. and Anderson, P. (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol., 169, 871-884. 80. Nair, A.P., Hirsch, H.H., Colombi, M. and Moroni, C. (1999) Cyclosporin A Promotes Translational Silencing of Autocrine Interleukin-3 via Ribosome-Associated Deadenylation. Mol. Cell. Biol., 19, 889-898. 81. Bickel, M., Cohen, R.B. and Pluznik, D.H. (1990) Post-transcriptional regulation of granulocyte-macrophage colony- stimulating factor synthesis in murine T cells. J Immunol, 145, 840-845. 82. Bevilacqua, A., Ceriani, M.C., Capaccioli, S. and Nicolin, A. (2003) Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol, 195, 356-372. 83. Chen, C.Y., Gherzi, R., Ong, S.E., Chan, E.L., Raijmakers, R., Pruijn, G.J., Stoecklin, G., Moroni, C., Mann, M. and Karin, M. (2001) AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell, 107, 451 - 464. 84. Gherzi, R., Lee, K.Y., Briata, P., Wegmuller, D., Moroni, C., Karin, M. and Chen, C.Y. (2004) A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell, 14, 571-583. 85. Raineri, I., Wegmueller, D., Gross, B., Certa, U. and Moroni, C. (2004) Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res, 32, 1279-1288. 86. Varnum, B.C., Lim, R.W., Sukhatme, V.P. and Herschman, H.R. (1989) Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene, 4, 119-120. 87. Varnum, B.C., Ma, Q.F., Chi, T.H., Fletcher, B. and Herschman, H.R. (1991) The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol. Cell. Biol., 11, 1754-1758. 88. Fan, X.C. and Steitz, J.A. (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci U S A, 95, 15293-15298. 89. Xu, N., Chen, C.-Y.A. and Shyu, A.-B. (2001) Versatile Role for hnRNP D Isoforms in the Differential Regulation of Cytoplasmic mRNA Turnover. Mol. Cell. Biol., 21, 6960-6971. 90. Misquitta, C.M., Iyer, V.R., Werstiuk, E.S. and Grover, A.K. (2001) The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem, 224, 53-67. 91. Eberhardt, W., Doller, A., Akool el, S. and Pfeilschifter, J. (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther, 114, 56-73. 92. Wilson, G.M., Lu, J., Sutphen, K., Sun, Y., Huynh, Y. and Brewer, G. (2003) Regulation of A + U-rich Element-directed mRNA Turnover Involving Reversible Phosphorylation of AUF1. J. Biol. Chem., 278, 33029-33038. 93. Winzen, R., Thakur, B.K., Dittrich-Breiholz, O., Shah, M., Redich, N., Dhamija, S., Kracht, M. and Holtmann, H. (2007) Functional Analysis of KSRP Interaction with the AU-Rich Element of Interleukin-8 and Identification of Inflammatory mRNA Targets. Mol. Cell. Biol., 27, 8388-8400. 94. Laroia, G., Cuesta, R., Brewer, G. and Schneider, R.J. (1999) Control of mRNA Decay by Heat Shock-Ubiquitin-Proteasome Pathway. Science, 284, 499-502. 95. Gilks, N., Kedersha, N., Ayodele, M., Shen, L., Stoecklin, G., Dember, L.M. and Anderson, P. (2004) Stress Granule Assembly Is Mediated by Prion-like Aggregation of TIA-1. Mol. Biol. Cell, 15, 5383-5398. 96. Taylor, G.A., Carballo, E., Lee, D.M., Lai, W.S., Thompson, M.J., Patel, D.D., Schenkman, D.I., Gilkeson, G.S., Broxmeyer, H.E., Haynes, B.F. et al. (1996) A Pathogenetic Role for TNF[alpha] in the Syndrome of Cachexia, Arthritis, and Autoimmunity Resulting from Tristetraprolin (TTP) Deficiency. Immunity, 4, 445-454. 97. Lai, W.S., Parker, J.S., Grissom, S.F., Stumpo, D.J. and Blackshear, P.J. (2006) Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol, 26, 9196-9208. 98. Stoecklin, G., Tenenbaum, S.A., Mayo, T., Chittur, S.V., George, A.D., Baroni, T.E., Blackshear, P.J. and Anderson, P. (2008) Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem, 283, 11689-11699. 99. Lai, W.S., Carrick, D.M. and Blackshear, P.J. (2005) Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover. J Biol Chem, 280, 34365-34377. 100. Carballo, E., Lai, W.S. and Blackshear, P.J. (2000) Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood, 95, 1891-1899. 101. Ogilvie, R.L., Abelson, M., Hau, H.H., Vlasova, I., Blackshear, P.J. and Bohjanen, P.R. (2005) Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol, 174, 953-961. 102. Suswam, E., Li, Y., Zhang, X., Gillespie, G.Y., Li, X., Shacka, J.J., Lu, L., Zheng, L. and King, P.H. (2008) Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res, 68, 674-682. 103. Sawaoka, H., Dixon, D.A., Oates, J.A. and Boutaud, O. (2003) Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. J Biol Chem, 278, 13928-13935. 104. Fechir, M., Linker, K., Pautz, A., Hubrich, T., Forstermann, U., Rodriguez-Pascual, F. and Kleinert, H. (2005) Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol Pharmacol, 67, 2148-2161. 105. Datta, S., Biswas, R., Novotny, M., Pavicic, P.G., Jr., Herjan, T., Mandal, P. and Hamilton, T.A. (2008) Tristetraprolin Regulates CXCL1 (KC) mRNA Stability. J Immunol, 180, 2545-2552. 106. Essafi-Benkhadir, K., Onesto, C., Stebe, E., Moroni, C. and Pages, G. (2007) Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell, 18, 4648-4658. 107. Lai, W.S., Carballo, E., Strum, J.R., Kennington, E.A., Phillips, R.S. and Blackshear, P.J. (1999) Evidence that Tristetraprolin Binds to AU-Rich Elements and Promotes the Deadenylation and Destabilization of Tumor Necrosis Factor Alpha mRNA. Mol. Cell. Biol., 19, 4311-4323. 108. Johnson, B.A., Stehn, J.R., Yaffe, M.B. and Blackwell, T.K. (2002) Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J Biol Chem, 277, 18029-18036. 109. Taylor, G.A., Thompson, M.J., Lai, W.S. and Blackshear, P.J. (1996) Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor. Mol Endocrinol, 10, 140 - 146. 110. Lykke-Andersen, J. and Wagner, E. (2005) Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev, 19, 351-361. 111. Sandler, H. and Stoecklin, G. (2008) Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans, 36, 491-496. 112. Fenger-Gron, M., Fillman, C., Norrild, B. and Lykke-Andersen, J. (2005) Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell, 20, 905-915. 113. Jing, Q., Huang, S., Guth, S., Zarubin, T., Motoyama, A., Chen, J., Di Padova, F., Lin, S.C., Gram, H. and Han, J. (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell, 120, 623-634. 114. Carman, J.A. and Nadler, S.G. (2004) Direct association of tristetraprolin with the nucleoporin CAN/Nup214. Biochem Biophys Res Commun, 315, 445-449. 115. Twizere, J.C., Kruys, V., Lefebvre, L., Vanderplasschen, A., Collete, D., Debacq, C., Lai, W.S., Jauniaux, J.C., Bernstein, L.R., Semmes, O.J. et al. (2003) Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst, 95, 1846-1859. 116. Chrestensen, C.A., Schroeder, M.J., Shabanowitz, J., Hunt, D.F., Pelo, J.W., Worthington, M.T. and Sturgill, T.W. (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem, 279, 10176-10184. 117. Stoecklin, G., Stubbs, T., Kedersha, N., Wax, S., Rigby, W.F., Blackwell, T.K. and Anderson, P. (2004) MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J, 23, 1313-1324. 118. Sun, L., Stoecklin, G., Van Way, S., Hinkovska-Galcheva, V., Guo, R.F., Anderson, P. and Shanley, T.P. (2007) Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem, 282, 3766-3777. 119. Deleault, K.M., Skinner, S.J. and Brooks, S.A. (2008) Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol, 45, 13-24. 120. Cao, H. (2004) Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications. Biochemistry, 43, 13724-13738. 121. Taylor, G.A., Thompson, M.J., Lai, W.S. and Blackshear, P.J. (1995) Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem, 270, 13341-13347. 122. Cao, H., Deterding, L.J., Venable, J.D., Kennington, E.A., Yates, J.R., 3rd, Tomer, K.B. and Blackshear, P.J. (2006) Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis. Biochem J, 394, 285-297. 123. Cao, H., Dzineku, F. and Blackshear, P.J. (2003) Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases. Arch Biochem Biophys, 412, 106-120. 124. Cao, H. and Lin, R. (2008) Phosphorylation of recombinant tristetraprolin in vitro. Protein J, 27, 163-169. 125. Cao, H., Deterding, L.J. and Blackshear, P.J. (2007) Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin. Expert Rev Proteomics, 4, 711-726. 126. Brooks, S.A., Connolly, J.E. and Rigby, W.F. (2004) The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol, 172, 7263-7271. 127. Keene, J.D. (1999) Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci U S A, 96, 5-7. 128. Jin, S.H., Kim, T.I., Yang, K.M. and Kim, W.H. (2007) Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR. Eur J Pharmacol, 558, 14-20. 129. Doller, A., Akool el, S., Huwiler, A., Muller, R., Radeke, H.H., Pfeilschifter, J. and Eberhardt, W. (2008) Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol, 28, 2608-2625. 130. Wang, W., Fan, J., Yang, X., Furer-Galban, S., Lopez de Silanes, I., von Kobbe, C., Guo, J., Georas, S.N., Foufelle, F., Hardie, D.G. et al. (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol, 22, 3425-3436. 131. van der Giessen, K., Di-Marco, S., Clair, E. and Gallouzi, I.E. (2003) RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem, 278, 47119-47128. 132. Gantt, K., Cherry, J., Tenney, R., Karschner, V. and Pekala, P.H. (2005) An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein {beta} (C/EBP{beta}) mRNA by HuR and its translocation to the cytosol. J Biol Chem, 280, 24768-24774. 133. Al-Ahmadi, W., Al-Ghamdi, M., Al-Haj, L., Al-Saif, M. and Khabar, K.S. (2009) Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res. 134. Inuzuka, H., Nanbu-Wakao, R., Masuho, Y., Muramatsu, M., Tojo, H. and Wakao, H. (1999) Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun, 265, 664-668. 135. Chen, Y.L., Huang, Y.L., Lin, N.Y., Chen, H.C., Chiu, W.C. and Chang, C.J. (2006) Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun, 346, 160-168. 136. Lal, A., Mazan-Mamczarz, K., Kawai, T., Yang, X., Martindale, J.L. and Gorospe, M. (2004) Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J, 23, 3092-3102. 137. Kaneda, N., Oshima, M., Chung, S.Y. and Guroff, G. (1992) Sequence of a rat TIS11 cDNA, an immediate early gene induced by growth factors and phorbol esters. Gene, 118, 289-291. 138. Taylor, G.A., Thompson, M.J., Lai, W.S. and Blackshear, P.J. (1996) Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor. Mol Endocrinol, 10, 140-146. 139. Murata, T., Yoshino, Y., Morita, N. and Kaneda, N. (2002) Identification of nuclear import and export signals within the structure of the zinc finger protein TIS11. Biochem Biophys Res Commun, 293, 1242-1247. 140. Khachigian, L.M. (2006) Early Growth Response-1 in Cardiovascular Pathobiology. Circ Res, 98, 186-191. 141. Beckmann, A.M. and Wilce, P.A. (1997) Egr transcription factors in the nervous system. Neurochem Int, 31, 477-510; discussion 517-476. 142. Chen, Z., Torrens, J.I., Anand, A., Spiegelman, B.M. and Friedman, J.M. (2005) Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab, 1, 93-106. 143. Boyle, K.B., Hadaschik, D., Virtue, S., Cawthorn, W.P., Ridley, S.H., O'Rahilly, S. and Siddle, K. (2009) The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation. Cell Death Differ, 16, 782-789. 144. Fumoto, T., Yamaguchi, T., Hirose, F. and Osumi, T. (2007) Orphan Nuclear Receptor Nur77 Accelerates the Initial Phase of Adipocyte Differentiation in 3T3-L1 Cells by Promoting Mitotic Clonal Expansion. J Biochem, 141, 181-192. 145. Chao, L.C., Bensinger, S.J., Villanueva, C.J., Wroblewski, K. and Tontonoz, P. (2008) Inhibition of Adipocyte Differentiation by Nur77, Nurr1, and Nor1. Mol Endocrinol, 22, 2596-2608. 146. Fajas, L., Miard, S., Briggs, M.R. and Auwerx, J. (2003) Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase. J. Lipid Res., 44, 1652-1659. 147. Xie, Y., Kang, X., Ackerman, W.E.t., Belury, M.A., Koster, C., Rovin, B.H., Landon, M.B. and Kniss, D.A. (2006) Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab, 8, 83-93. 148. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C. and Jakob, F. (2005) Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal, 3, 5. 149. Lim, I.K. (2006) TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol, 132, 417-426. 150. Frevel, M.A.E., Bakheet, T., Silva, A.M., Hissong, J.G., Khabar, K.S.A. and Williams, B.R.G. (2003) p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts. Mol. Cell. Biol., 23, 425-436. 151. Phillips, K., Kedersha, N., Shen, L., Blackshear, P.J. and Anderson, P. (2004) Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA, 101, 2011 - 2016. 152. Worthington, M.T., Pelo, J.W., Sachedina, M.A., Applegate, J.L., Arse-neau, K.O. and Pizarro, T.T. (2002) RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J Biol Chem, 277, 48558 - 48564. 153. Murata, T., Yoshino, Y., Morita, N. and Kaneda, N. (2002) Identification of nuclear import and export signals within the structure of the zinc finger protein TIS11. Biochem Biophys Res Commun, 293, 1242 - 1247. 154. Phillips, R.S., Ramos, S.B.V. and Blackshear, P.J. (2002) Members of the Tristetraprolin Family of Tandem CCCH Zinc Finger Proteins Exhibit CRM1-dependent Nucleocytoplasmic Shuttling. J. Biol. Chem., 277, 11606-11613. 155. Lai, W.S., Thompson, M.J., Taylor, G.A., Liu, Y. and Blackshear, P.J. (1995) Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem, 270, 25266 - 25272. 156. Lai, W.S., Stumpo, D.J. and Blackshear, P.J. (1990) Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem, 265, 16556 - 16563. 157. Lai, W.S., Kennington, E. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43010 | - |
dc.description.abstract | 脂肪組織為身體的重要器官,掌管體內能量恆定,且可釋放多種激素以調節體內各種生理功能,脂肪細胞分化的異常可能引起肥胖以及相關的疾病。在以3T3-L1脂肪前驅細胞為模式的研究中發現,當細胞受到分化刺激時,多種極早期基因(immediate early gene)的表現會受到活化,包括RNA降解因子tristetraprolin (TTP),TTP可藉由與mRNA 3’端非轉譯區(3’ untranslated region, 3’UTR)中特殊的多腺嘌呤-尿嘧啶序列(AU-rich element, ARE)結合而加速其降解,本論文的目標即在瞭解TTP在調節脂肪細胞分化過程中的角色。將與TTP結合的mRNA分離並鑑定後,發現TTP的表現可受到自我調控,TTP可藉由與自己的mRNA結合而降低本身的表現。本研究也分離到TTP的新標的─MKP-1 mRNA。研究發現當脂肪細胞受到分化刺激後,ERK pathway同時活化TTP與MKP-1的表現,MKP-1的表現可抑制ERK活性,進而造成此一訊息傳遞的負調控。而MKP-1的表現則受到TTP及另一個RNA結合因子HuR的調控,TTP與MKP-1 mRNA的結合造成RNA降解而抑制MKP-1表現,HuR與MKP-1的結合則可使MKP-1 mRNA更加穩定。MKP-1 3’UTR具有三段ARE,在RNA IP、RNA pull-down及REMSA等實驗中證實他們對TTP及HuR有不同的親和力,證據指出TTP與HuR皆傾向與ARE1和ARE2結合,對ARE3的結合力較低,有趣的是,即便如此,TTP仍可藉由其他不明方式調節ARE3。進一步研究發現,TTP對RNA的親和力可受到轉譯後修飾機制(posttranslational modification)的調節。p38 pathway的活化使TTP呈高度磷酸化的狀態,且對RNA的親和力降低;而ERK pathway造成的磷酸化雖然對TTP的分子量影響不大,但卻能有效增加其對RNA的親和力。另外,在進行RNA干擾(RNAi)實驗後發現,抑制TTP的表現同時也抑制脂肪細胞分化,但抑制MKP-1表現後,脂肪細胞的複製擴增(mitotic clonal expansion)增加且分化的程度更加提高,此結果顯示TTP及MKP-1在調節脂肪細胞分化有重要的功能。綜合上述,本研究顯示MAPK pathway可活化TTP基因的轉錄,又可藉由轉譯後修飾機制影響TTP的功能,而TTP可藉由調節MKP-1的表現而影響MAPK pathway的活性,彼此間形成精密的調控網絡,進而控制脂肪細胞分化。 | zh_TW |
dc.description.abstract | Dysregulation of adipogenesis has been considered as a cause of the development of obesity and obesity-related diseases. Among the immediate early genes (IEGs) activated during the differentiation of 3T3-L1 preadipocytes, we identified tristetraprolin (TTP), a zinc finger-containing RNA-binding protein which was reported to bind AU-rich elements (AREs) of target mRNAs and induce their rapid degradation. To understand how TTP may be involved in regulating adipogenesis, the expression and mRNA targets of TTP were analyzed. Biochemical and functional assays showed that the expression of TTP per se was autoregulated. Sequence analysis of 3’UTR of IEG mRNAs differentially bound by TTP suggested a preferential binding sequence of UUAUUUAUU. In addition to TTP and the previously reported COX-2 mRNAs, we have also identified MKP-1 mRNA as a novel target of TTP. The expression of MKP-1 and TTP was simultaneously activated by ERK signaling, while MKP-1 protein functions as a feedback regulator of ERK. Moreover, the expression of MKP-1 was tightly controlled by ARE-binding proteins TTP and HuR. Binding of TTP to MKP-1 mRNA resulted in rapid decay and binding of HuR resulted in mRNA stabilization. The three AREs in MKP-1 3’UTR were differentially bound by TTP and HuR. More specifically, both of TTP and HuR preferentially bound to MKP-1 ARE1 and ARE2, but showed low binding affinity to MKP-1 ARE3. The RNA-binding affinity of TTP was posttranslationally modified by p38 and ERK signaling. TTP exhibited a decreased RNA binding while being phosphorylated by p38 signaling and showed an enhanced RNA binding while being phosphorylated by ERK signaling. The functional importance of TTP and MKP-1 during 3T3-L1 differentiation was further demonstrated by siRNA knockdown experiment. These results suggested that TTP can regulate the MKP-1 mRNA stability to subsequently control the activation of MAPK signaling pathways in adipocyte differentiation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:32:41Z (GMT). No. of bitstreams: 1 ntu-98-F90629016-1.pdf: 9503142 bytes, checksum: 9a3012cad19f1579ef1efae58bde9e15 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 誌謝 ................................................................................................................... i
中文摘要 ....................................................................................................................... iii Abstract ......................................................................................................................... v Contents ......................................................................................................................... vii Abbreviations ............................................................................................................... xi I. Introduction .................................................................................................................. 1 1. Adipogenesis and diseases .................................................................................. 1 2. Molecular regulation of adipogenesis ................................................................ 10 3. Modulation of gene expression through posttranscriptional regulation ............ 23 4. TTP-regulated RNA decay ............................................................................... 33 II. Material and Methods .............................................................................................. 43 1. Cell culture .........................................................................................................43 2. Plasmid constructs ............................................................................................. 43 3. RNA extraction and reverse-transcription ....................................................... 45 4. Semiquantitative PCR ....................................................................................... 45 5. Real-time PCR ……………….......................................................................... 46 6. Preparation of whole cell extracts and cytoplasmic/nuclear extracts and Western blotting assay ..................................................................................... 47 7. RNA pull-down assay ........................................................................................ 48 8. RNA-immunoprecipitation assays ................................................................... 49 9. RNA EMSA ...................................................................................................... 50 10. Luciferase reporter assay and Northern blotting ........................................... 51 11. RNA interferences .......................................................................................... 52 III. Specific Aims ......................................................................................................... 53 IV. Results ................................................................................................................... 55 1. Analysis of expression kinetics of TTP and the possible autoregulation during 3T3-L1 differentiation .......................................................................... 55 2. Identification of novel TTP-targeted mRNAs during 3T3-L1 differentiation … 60 3. Molecular functions of MKP-1 during 3T3-L1 differentiation ……………….. 64 4. ERK signaling modulates MKP-1 mRNA expression transcriptionally and posttranscriptionally .......................................................................................... 65 5. Physical interaction between TTP and three MKP-1AREs …………………… 67 6. HuR stabilized MKP-1 mRNA through interaction to MKP-1 ARE1 and ARE2 ................................................................................................................ 70 7. Posttranslational modification regulated the RNA-binding affinity of TTP ….. 70 8. Knocked-down MKP-1 expression enhanced adipocyte differentiation ……… 72 V. Conclusions ............................................................................................................. 75 VI. Discussion ............................................................................................................... 77 VII. Figures .................................................................................................................. 85 Figure 1 Morphological changes of 3T3-L1 during differentiation ………………… 86 Figure 2 Expression of TTP mRNA and protein during differentiation of 3T3-L1 preadipocytes .............................................................................................. 87 Figure 3 Expression of TTP mRNA and protein stimulated by different inducers … 89 Figure 4 Half-life of TTP mRNAs shortened after induction to differentiate ….…… 91 Figure 5 Interaction between TTP and HuR proteins and TTP AREs ….…………… 92 Figure 6 Functional characterization of TTP and HuR-mediated ARE-containing TTP mRNA expression .............................................................................. 97 Figure 7 RNA interferences of TTP expression down-regulated 3T3-L1 differentiation .............................................................................................. 100 Figure 8 mRNA metabolism of the IEGs during the early differentiation of 3T3-L1 cells ........................................................................................................... 102 Figure 9 TTP could interact with MKP-1 and COX-2 mRNA. (A) RNA-IP analysis .................................................................................................... 103 Figure 10 Expression profiling of MAPKs and MKP-1 during differentiation of 3T3-L1 cells ….......................................................................................... 105 Figure 11 ERK signaling regulates MKP-1 mRNA expression in differentiation of 3T3-L1 cells .................................................................................. 108 Figure 12 ERK signaling induced TTP expression and downregulated MKP-1 mRNA stability ...................................................................................... 109 Figure 13 Interaction between MKP-1 AREs and endogenous TTP and HuR from 3T3-L1 cytosol ............................................................................. 111 Figure 14 MKP-1 AREs mediated posttranscriptional gene regulation and were down-regulated by TTP overexpression ................................................. 113 Figure 15 TTP showed strong interaction to MKP-1 ARE1 and ARE2, but weak interaction to ARE3 ………….………………………………………….. 116 Figure 16 HuR stabilized MKP-1 mRNA stability by interacting with ARE1 and ARE2, but not with ARE3 ........................................................................ 119 Figure 17 Posttranslational modification regulated the RNA-binding affinity and RNA-destabilizing effect of TTP .................................................. 121 Figure 18 Inhibited TTP and MKP-1 expression altered adipocyte differentiation processes ................................................................................................... 124 Figure 19 Hypothesized regulatory networks between MAPKs, MKP-1 and RNA-destabilizing factor TTP during the early differentiation of 3T3-L1 cells. …………………………………………………………..... 125 VIII. Tables .................................................................................................................. 127 Table 1 Primers used to characterize the IEGs expression in differentiation of 3T3-L1 cells by real-time PCR ................................................................... 127 Table 2 Characteristics of IEG’s AREs ..................................................................... 128 IX. Supplemental Data ................................................................................................ 129 Figure 1 HuR could interact with ARE-containing IEG mRNAs ............................. 129 X. References ............................................................................................................... 131 | |
dc.language.iso | en | |
dc.title | 脂肪細胞分化過程中TTP、MKP-1與MAPK訊息傳遞路徑間之調控機制 | zh_TW |
dc.title | The Regulatory Network between TTP, MKP-1 and MAPK Signaling in Adipogenesis | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 張?仁 | |
dc.contributor.oralexamcommittee | 呂勝春,詹東榮,譚賢明,李玉梅 | |
dc.subject.keyword | 脂肪細胞分化,多腺嘌呤-尿嘧啶序列,TTP,MKP-1,轉錄後調節機制,轉譯後修飾機制, | zh_TW |
dc.subject.keyword | adipogenesis,ARE,TTP,MKP-1,posttranscriptional regulation,posttranslational modification, | en |
dc.relation.page | 143 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-20 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
顯示於系所單位: | 獸醫學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 9.28 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。